Deakin Bio-Hybrid Materials Ltd - Accounts to registrar (filleted) - small 23.2.5

REGISTERED NUMBER: 13439437 (England and Wales)

Deakin Bio-Hybrid Materials Ltd

Unaudited Financial Statements

for the Year Ended 30th June 2023

Page

Company Information

1

Chartered Certified Accountants' Report

2

Balance Sheet

3

Notes to the Financial Statements

5

DIRECTOR:

Dr A D Roberts

REGISTERED OFFICE:

69 Lambeth Walk

London

SE11 6DX

REGISTERED NUMBER:

13439437 (England and Wales)

ACCOUNTANTS:

Naail & Co

Chartered Certified Accountants

69 Lambeth Walk

London

SE11 6DX

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Abridged Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Deakin Bio-Hybrid Materials Ltd for the year ended 30th June 2023 which comprise the Abridged Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the director of Deakin Bio-Hybrid Materials Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Deakin Bio-Hybrid Materials Ltd and state those matters that we have agreed to state to the director of Deakin Bio-Hybrid Materials Ltd in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Deakin Bio-Hybrid Materials Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Deakin Bio-Hybrid Materials Ltd. You consider that Deakin Bio-Hybrid Materials Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Deakin Bio-Hybrid Materials Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Naail & Co

Chartered Certified Accountants

69 Lambeth Walk

London

SE11 6DX

Date: .............................................

FIXED ASSETS

Property, plant and equipment

5

2,428

-

CURRENT ASSETS

Cash at bank and in hand

5,987

627

CREDITORS

Amounts falling due within one year

6

54,898

4,153

NET CURRENT LIABILITIES

(48,911

)

(3,526

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(46,483

)

(3,526

)

PROVISIONS FOR LIABILITIES

7

461

-

NET LIABILITIES

(46,944

)

(3,526

)

CAPITAL AND RESERVES

Called up share capital

8

100

100

Retained earnings

9

(47,044

)

(3,626

)

SHAREHOLDERS' FUNDS

(46,944

)

(3,526

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement for the year ended 30th June 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12th December 2023 and were signed by:

Dr A D Roberts - Director

1.	STATUTORY INFORMATION

Deakin Bio-Hybrid Materials Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

The turnover is generated from the ordinary activities of the business and is recognised when the right to consideration becomes due.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern

At the balance sheet date, the company's liabilities exceeded its assets. The company is able to trade with the support of its director and in his opinion, this support will continue for the foreseeable future and for at least 13 months from the date of approval of these financial statements. The financial statements are therefore prepared on the going concern basis.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

5.	PROPERTY, PLANT AND EQUIPMENT

Computer

equipment

£

COST

Additions

3,237

At 30th June 2023

3,237

DEPRECIATION

Charge for year

809

At 30th June 2023

809

NET BOOK VALUE

At 30th June 2023

2,428

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2023

2022

£

£

Trade creditors

-

120

Social security and other taxes

12,640

-

Pensions

1,753

-

Directors' current accounts

40,505

4,033

54,898

4,153

7.	PROVISIONS FOR LIABILITIES

2023

2022

£

£

Deferred tax

461

-

Deferred

tax

£

Utilised during year

461

Balance at 30th June 2023

461

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2023

2022

value:

£

£

100

Ordinary

£

100

100

9.

RESERVES

Retained

earnings

£

At 1st July 2022

(3,626

)

Deficit for the year

(43,418

)

At 30th June 2023

(47,044

)

10.	RELATED PARTY DISCLOSURES

Dr A D Roberts

Director & 100% shareholder

At the reporting date, the company owed £40,505 (2022: £4,033) to Mr Roberts. This is an interest free loan with no set repayment terms.

11.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr A D Roberts.